FEMY Femasys Corp: Accounting Value per Share

Graphic logo of Femasys Inc (FEMY)

Femasys Inc. is scaling the FemaSeed system and developing the FemBloc drug, relying on contract component assembly and external logistics. Patent protection for its instruments ensures premium pricing. The book value per share ratio on the GURU.Markets chart confirms this data, where 1.32 reflects the latest metric value, helping investors assess the company's real net asset value.

Femasys Inc (FEMY) - Accounting Value per Share from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for femasys.com (FEMY)

- price and consensus price forecast:
Price Chart Femasys Corp|FEMY - Consensus Target
- market capitalization data:
Market Valuation Femasys Inc.|FEMY - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Femasys|FEMY - Company Net Assets|Market Capitalization to Book Value Ratio femasys.com|FEMY - Company Assets
- debt and liquidity data:
Total Debt to Capital Femasys Inc.|FEMY - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Femasys|FEMY - Company Total Debt Obligations|Debts to Book Capitalization Femasys Inc.
Analysis of all company metrics:Femasys Corp - FEMY
Manufactured product of femasys.com

High marketing expenditures by Femasys Inc. (FEMY) for FemTech solutions and regulatory barriers directly impact the volume of equity. This metric quantifies the share of net assets available to the owner of each share, allowing for an assessment of the real value of assets minus liabilities. By analyzing the book value per share, an investor determines business stability, taking into account the risk of capitalization stagnation despite an increase in the book value.

Competitors of Femasys Inc. (FEMY)

ISRG: Net Assets per Single Share|Danaher Corporation Inc. (DHR) - Accounting Value per Share|Accounting Value per Share BDX|STE (steris.com) - Net Asset Value per Share|Net Assets per Single Share WST|Accounting Value per Share Baxter International Inc.|Masimo Personal Health - Book Value per Share|Net Asset Value per Share Stevanato Group Corp (STVN)|TFX - Book Value per Share|Equity per Share merit.com MMSI|Book Value per Share NVST (Envista)|ICUI - Net Assets per Share|XRAY (Dentsply) - Book Value per Share|LeMaitre Corp (LMAT) - Accounting Value per Share|ATRC (AtriCure, Inc.) - Book Value per Share|Book Value per Share STAA|Net Assets per Single Share ChromaDex Corporation (NAGE)|Net Assets per Single Share ZimVie Inc ZIMV|Accounting Value per Share AngioDynamics Corp|Accounting Value of a Share Cerus Inc CERS|Book Value per Share TKNO (Alpha Teknova, Inc.)|MGRM: Net Assets per Share|Net Assets per Single Share sharpstechnology.com|INFU (InfuSystem Holdings, Inc.) - Equity per Share|UTMD: Net Assets per Single Share|Net Assets per Share KORU Medical Systems Inc. (KRMD)|Accounting Value per Share Nyxoah S.A.|Book Price of a Share MBOT (microbotmedical.com)|Net Assets per Single Share Pro-Dex|ZTEK - Accounting Value of a Share|Elutia Corp - Accounting Value per Share|MLSS: Book Value per Share|NXGL (NEXGEL, Inc.) - Net Assets per Single Share|Retractable Technologies, Inc. (RVP) - Accounting Value per Share|Book Value per Share HBIO (Harvard Bioscience, Inc.)|Net Asset Value per Share MHUA|Net Assets per Single Share Predictive Oncology POAI|Equity per Share callanjmb.com CJMB|Accounting Value per Share Atrion Corporation (ATRI)|neurometrix.com - Book Price of a Share